Search Results

Search Results

Research Study Search Results

Return to Search Form
  1. Rheumatology

      1. Ankylosing Spondylitis

        1. Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis Philip J. Mease, MD
        2. 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients Philip J. Mease, MD
      2. Axial Spondyloarthritis

        1. A Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects with Non-Radiographic Axial Spondyloarthritis. Philip J. Mease, MD
      3. Osteoporosis

        1. Teriparatide and Risedronate in the Treatment of Patients with Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures. Christopher Shuhart, MD, MHA
      4. Psoriatic Arthritis

        1. Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors (OPAL BEYOND) Philip J. Mease, MD
        2. Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis (AMVISION-1) Philip J. Mease, MD
        3. Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis (AMVISION-2) Philip J. Mease, MD
        4. Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (OPAL BALANCE) Philip J. Mease, MD
        5. Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis Philip J. Mease, MD
        6. Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study (OPAL BROADEN) Philip J. Mease, MD
        7. Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis (ASTRAEA) Philip J. Mease, MD
        8. A Study of Ixekizumab in Participants With Active Psoriatic Arthritis (SPIRIT-P1) Philip J. Mease, MD
      5. Rheumatoid Arthritis

        1. Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Patients (DARWIN1) Philip J. Mease, MD
        2. A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics Philip J. Mease, MD
        3. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) Philip J. Mease, MD
        4. A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy Philip J. Mease, MD
      6. Systemic Lupus Erythematosis (SLE)

        1. Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) (EMBODY 2) Philip J. Mease, MD
        2. A study of the effectiveness and safety of Epratuzumab in Systemic Lupus Erythematosis (SLE) (EMBODY) Philip J. Mease, MD